<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2011-3377-998-12262</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="SV">*Super Epitoper* vid Sv&#xE5;r Malaria</narrative>
   <narrative xml:lang="EN">*Super-epitopes* in Severe Malaria</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Plasmodium falciparum undergoes antigenic variation to establish persistent blood stage infections. The major variant antigen, PfEMP1, is expressed at the erythrocyte surface where it acts as a virulence adhesion molecule bringing about severe malaria through accumulation of infected and uninfected erythrocytes in the micro-vasculature. We hypothesize that subgroups of cross-reactive PfEMP1 sequences are recognized by the immune-system and that certain antibodies are key in the protection against severe malaria. In this proposal we suggest to identify specific structures in PfEMP1 that induce broad and potent antibodies inhibiting sequestration in severe malaria. In our approach to achieve this ambitious goal, we will develop new methods for the identification of surface exposed epitopes, cross-reactivities between epitopes and receptor-binding structures in PfEMP1. This will be accomplished in five parallel discovery programs and in one for validation including isolation of I) antibodies to PfEMP1, II) cross-reactive IgG on random- and specific peptide libraries, III) human memory B cells/ antibodies, IV) fresh isolates from Uganda and V) creation of a super cross-reactive epitope. Candidate structures will be validated using state-of-the-art methods to investigate the specificity, quality and quantity of immunity to PfEMP1. The project is likely to reveal the Achilles heal of the parasites immune evasion strategy and will be useful for the design of a vaccine.</narrative>
   <narrative xml:lang="SV">Totalt 300 miljoner insjuknar varje &#xE5;r i malaria och 1 miljoner individer avlider i sjukdomen. Den drabbar hela det globala samh&#xE4;llet men det &#xE4;r de fattiga befolkningarna i Afrika, Asien och Syd-Amerika som &#xE4;r de mest utsatta. I det h&#xE4;r projektet skall vi unders&#xF6;ka hur malaria parasiten Plasmodium falciparum uttrycker ett relativt variabelt &#xE4;ggvite&#xE4;mne som binder till sig r&#xF6;dablodkroppar trots att den ocks&#xE5; har tillskansat sig &#xF6;verlevnads f&#xF6;rdelar genom att st&#xE4;ndigt &#xE4;ndra sitt yttre, st&#xE4;ndigt &#xE4;ndra generna i sitt inre. Parasitytan best&#xE5;r av ett f&#xE5;tal &#xE4;ggvite&#xE4;mnen som utbytes i en kappl&#xF6;pning med immunsystemet. Det m&#xF6;jligg&#xF6;r f&#xF6;r parasiten att &#xF6;verleva mitt i blodomloppet och spridas vidare till andra individer. Vi har dock nyligen uppt&#xE4;ckt att parasiten ocks&#xE5; har en Akilleus h&#xE4;l; den uttrycker i relativt stor omfattning liknande &#xE4;ggvitesekvenser p&#xE5; ytan av den infekterade r&#xF6;da blodkroppen. Vi skall nu i detalj unders&#xF6;ka f&#xF6;rekomsten av semi-konserverade sekvenser hos dessa proteiner som m&#xE4;nniskans immunsystem kan k&#xE4;nna igen allt f&#xF6;r att utveckla ett vaccin som i det l&#xE5;nga loppet kan komma att anv&#xE4;ndas vid profylaktisk vaccinering. Vi skall unders&#xF6;ka hur vanligt f&#xF6;rekommande detta &#xE4;ggvite&#xE4;mne &#xE4;r i parasiter som kommer direkt fr&#xE5;n komat&#xF6;sa barn eller de som har mer okomplicerade former av sjukdomen.</narrative>
  </description>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">University, college or other teaching institution, research institute or think-tank</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2012-01-01" type="1"></activity-date>
  <activity-date iso-date="2012-01-01" type="2"></activity-date>
  <activity-date iso-date="2014-12-31" type="3"></activity-date>
  <activity-date iso-date="2014-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="998" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Developing countries, unspecified</narrative>
  </recipient-region>
  <sector code="122" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Basic Health</narrative>
  </sector>
  <sector code="12262" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Malaria control</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2013-01-01"></period-start>
   <period-end iso-date="2013-12-28"></period-end>
   <value currency="USD" value-date="2013-01-01">130504.2068414911</value>
  </budget>
  <budget>
   <period-start iso-date="2014-01-01"></period-start>
   <period-end iso-date="2014-12-28"></period-end>
   <value currency="USD" value-date="2014-01-01">123908.5117858861</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-10-27"></transaction-date>
   <value currency="USD" value-date="2011-10-27">392960.6114775319</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-01-28"></transaction-date>
   <value currency="USD" value-date="2014-01-28">123908.5117858861</value>
  </transaction>
  <document-link format="APPLICATION/PDF" url="http://upload.openaid.se/document/vetenskapsradet/generalla-villkor-2012.pdf">
   <title>
    <narrative xml:lang="SV">Generella bidragsvillkor 2012</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
